Azygos vein lead implantation for high defibrillation thresholds in implantable cardioverter defibrillator placement

Indian Pacing and Electrophysiology Journal

Volumn 10, Issue 1, 2010, Pages 49-54

  Kommuri, Naga V A ^a   Kollepara, Sri Lakshmi S ^a   Saulitis, E ^a   Siddiqui, Mukarram A ^a  

^a SINAI GRACE HOSPITAL   (United States)

Author keywords

Azygos vein lead; High defibrillation threshold; Implantable cardioverter defibrillator

Indexed keywords

LEAD;

ADULT; AGED; ARTICLE; AZYGOS VEIN; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; DEFIBRILLATOR; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; SICKLE CELL ANEMIA; SUDDEN DEATH; SUPERIOR CAVA VEIN; VASCULAR ACCESS;

EID: 74949106393     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Echt DS, Armstrong K, Schmidt P, et al. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation. 1985;71:289-96.
2. Pires LA, Hull ML, Nino CL, et al. Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: terminal events, predictors, and potential mechanisms. J Cardiovasc Electrophysiol. 1999;10:1049-56.
3. Russo AM, Sauer W, Gerstenfeld EP, et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter- defibrillator insertion? Heart Rhythm. 2005;2:456-61.
4. Epstein AE, Ellenbogen KA, Kirk KA, et al. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation. 1992;86:1206-16.
5. Strickberger SA, Daoud EG, Davidson T, et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation. 1997; 96:1217-23.
6. Uyguanco ER, Berger A, Budzikowski AS, et al. Management of high defibrillation threshold. Expert Rev Cardiovasc Ther. 2008:1237-48.
7. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation. 1995; 92:59-65.
8. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337:1576-83.
9. Mirowski M, Mower MM, Gott VL, Brawley RK. The feasibility and effectiveness of lowenergy catheter defibrillation in man. Circulation 1973; 47:79-85.
10. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol. 2007; 30:675-700.
11. Nagai T, Kurita T, Satomi K, et al. QRS Prolongation is Associated With High Defibrillation Thresholds During Cardioverter-Defibrillator Implantations in Patients With Hypertrophic Cardiomyopathy. Circ J. 2009; 73:1028-32.
12. Cesario D, Bhargava M, Valderrábano M, et al. Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement. J Cardiovasc Electrophysiol. 2004;15:780-3.
13. Cooper JA, Latacha MP, Soto GE, et al. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series. Pacing Clin Electrophysiol. 2008; 31:1405-10.
14. Aguel F, Eason JC, Trayanova NA, et al. Impact of transvenous lead position on active-can ICD defibrillation: A computer simulation study. Pacing Clin Electrophysiol 1999;22:158-164.
15. Haffajee C, Martin D, Bhandari A, et al. A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system. Jewel Active Can Investigators. Pacing Clin Electrophysiol. 1997; 20:215-9.
16. Shukla HH, Flaker GC, Jayam V, Roberts D. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol. 2003; 26:44-8.
17. Yamanouchi Y, Mowrey KA, Niebauer MJ, et al. Additional lead improves defibrillation efficacy with an abdominal 'hot can' electrode system. Circulation. 1997;96:4400-7.